Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2008
11/27/2008US20080293825 Hydroalcoholic antimicrobial composition with skin health benefits
11/27/2008US20080293785 Substituted benzothiazole kinase inhibitors
11/27/2008US20080293783 Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents
11/27/2008US20080293760 Gemifloxacin Process and Polymorphs
11/27/2008US20080293745 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/27/2008US20080293727 Amine hydroxyalkyl sulfonamides as enzyme inhibitors; for example, N-1-(3-((3-acetylamino-4-fluoro-benzenesulfonyl)-benzyl-amino)-(1S,2 syn)-1-benzyl-2-hydroxy-propyl)-2-((quinoline-2-carbonyl)-amino)-succinamide; may be used as anti-viral agents against the HIV-1 and HIV-2 viruses
11/27/2008US20080293725 Prognostic Molecular Markers
11/27/2008US20080293721 Arylthioacetamide carboxylate derivatives as fkbp inhibitors for the treatment of neurological diseases
11/27/2008US20080293703 Topical Preparation and Method for Transdermal Delivery and Localization of Therapeutic Agents
11/27/2008US20080293685 Spiro and other derivatives of diamondoids possessing therapeutic activity in the treatment of viral disorders
11/27/2008US20080293668 [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides
11/27/2008US20080293667 Lipid analogs for combating tumors
11/27/2008US20080293666 Antibacterial Agents
11/27/2008US20080293664 Non-nucleoside reverse transcriptase inhibitors
11/27/2008US20080293662 RNAi MODULATION OF THE BCR-ABL FUSION GENE AND USES THEREOF
11/27/2008US20080293657 Modulation of the expression of stat-1-dependent genes
11/27/2008US20080293649 Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents
11/27/2008US20080293646 Macrolides
11/27/2008US20080293630 Mucoadhesive Pharmaceutical Compositions Comprising Chemoattractants
11/27/2008US20080293623 Enriched haptoglobin polymers for the treatment of disease
11/27/2008US20080293619 Compositions and methods for treating malaria with cupredoxin and cytochrome
11/27/2008US20080293126 Novel Lactobacillus Living Body Activating Lactobacillus Preparation and Preventive or Therapeutic Agent for Living Body Infection
11/27/2008US20080293103 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
11/27/2008US20080292733 Antioxidant and Fe2+ Chelating Properties of Herbal Extracts
11/27/2008US20080292732 Plant and Plant Storage Organ Having Glp-1 Derivative Accumulated Therein and Method of Producing the Same
11/27/2008US20080292726 Ophthalmic gallium compositions and methods of their use
11/27/2008US20080292707 Pharmaceutical Compositions of Adsorbates of Amorphous Drug
11/27/2008US20080292663 Adjuvant compositions and methods for delivering vaccines
11/27/2008US20080292662 Vaccine Comprising Recombinant Clpp Protein of Streptococcus Pneumoniae
11/27/2008US20080292660 Hexavalent Bovine Rotavirus Reassortant Composition Designed for Use in Developing Countries
11/27/2008US20080292658 Defective Influenza Virus Particles
11/27/2008US20080292653 Live attenuated antigenically marked classical swine fever virus
11/27/2008US20080292650 Therapeutic and diagnostic peptides
11/27/2008US20080292648 Synthetic agonists of tlr9
11/27/2008US20080292646 Recombinant fusion protein and polynucleotide construct for immunotoxin production
11/27/2008US20080292645 Antibody or Antibody Fragment Coupled with an Immunogenic Agent
11/27/2008US20080292642 Crystalline anti-human IL-12 antibodies
11/27/2008US20080292638 monoclonal antibodies or antigen-binding fragments, that neutralize mature human transforming growth factors, useful for treating cell proliferative disorders in mammals
11/27/2008US20080292631 Treatment with anti-vegf antibodies
11/27/2008US20080292630 Treatment with anti-vegf antibodies
11/27/2008US20080292624 Method of detecting and treating tuberous sclerosis complex associated disorders
11/27/2008US20080292620 PRLR-Specific Antibody and Uses Thereof
11/27/2008US20080292618 Intranuclear protein transduction through a nucleoside salvage pathway
11/27/2008US20080292614 DNA sequences for human angiogenesis genes
11/27/2008US20080292602 T Cell Receptors Which Specifically Bind to Vygfvracl-Hla-A24
11/27/2008US20080292592 treating, preventing cancer using compositions including replication competent adenovirus; death domains; rapid and efficient spread through the tumor
11/27/2008US20080292588 hepatitis C virus; 5-(4-fluoro-benzyl)-8-hydroxy-7-(1-methyl-1 oxo-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-5-aza-spiro[2.5]oct-7-en-6-one
11/27/2008US20080292587 Oximyl dipeptide hepatitis c protease inhibitors
11/27/2008US20080292586 Method and Use of Interferon Compositions For the Treatment of Avian Influenza
11/27/2008US20080292559 Method of treating tuberculosis with interferons
11/27/2008US20080292549 High Affinity Melan-A T Cell Receptors
11/27/2008US20080292546 Compositions and methods for treating and diagnosing cancer
11/27/2008US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/27/2008DE202008012041U1 Vaginalzäpfchen auf Basis von 3,3'-Dindolylmethan (Methindol) Vaginal suppositories based on 3,3'-Dindolylmethan (Methindol)
11/27/2008DE10251709B4 Screening-Verfahren für Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 Screening method for agents to stimulate the human beta-defensins type 2 and / or type 3
11/27/2008DE102007024377A1 Antiseptic cosmetic skin cleansing and/or care composition, useful for combating bacterial, fungal and/or viral skin infections, contains photoactive metal oxide, e.g. titanium dioxide
11/27/2008DE102007013281B4 Warzenmittel Wart
11/27/2008CA2688554A1 Dose forms comprising vx-950 and their dosage regimen
11/27/2008CA2688142A1 A process for stereoselective synthesis of lamivudine
11/27/2008CA2688008A1 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
11/27/2008CA2687878A1 Antiviral agents
11/27/2008CA2687647A1 Tenofovir disoproxil hemi-fumaric acid co-crystal
11/27/2008CA2687535A1 Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activity
11/27/2008CA2687523A1 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008CA2686348A1 Bactericidal anti-mrsa active pharmaceutical composition containing carbapenems
11/27/2008CA2685112A1 Triazol compounds for treating biofilm formation
11/27/2008CA2684692A1 Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
11/27/2008CA2684150A1 Induction of a physiological dispersion response in bacterial cells in a biofilm
11/27/2008CA2683350A1 Nitrogenous heterocyclic compounds, preparation thereof and use thereof a antibacterial medicaments
11/26/2008EP1995227A1 Spiro and other derivatives of diamondoids posessing therapeutic activity in the treatment of viral disorders
11/26/2008EP1994941A2 Medicine containing at least one oxidised protein
11/26/2008EP1994938A1 New lipoglycodepsipeptide compositions
11/26/2008EP1994936A1 Lactobacilli for the prevention of mastitis and for reducing the risk of allergy in breast-fed infants
11/26/2008EP1994930A1 Triazol compounds for treating biofilm formation
11/26/2008EP1994928A1 Antimicrobial agent and antimicrobial composition
11/26/2008EP1994927A1 Diamondoid derivatives possessing therapeutic activity in the treatment of viral disorders
11/26/2008EP1994491A2 Flavivirus inhibition by sultams and related compounds
11/26/2008EP1994152A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/26/2008EP1994151A2 Compositions and methods for detection and treatment of human herpesvirus (hhv)-6
11/26/2008EP1994044A2 DERIVATIVES OF 18ß-GLYCYRRHETINIC ACID
11/26/2008EP1994020A2 Substituted quinolones iii
11/26/2008EP1993994A2 Deuterated hepatitis c protease inhibitors
11/26/2008EP1993585A2 Use of the long pentraxin ptx3 for the prevention or treatment of viral diseases
11/26/2008EP1993567A2 Orally administrable gallium compositions and method of use
11/26/2008EP1993564A1 Method and composition for treating allergic diseases
11/26/2008EP1993549A1 Medicament formulations comprising fluoroquinolones
11/26/2008EP1993547A2 Prodrugs of benzoquinolizine-2-carboxylic acid
11/26/2008EP1883641B1 Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them, and their use
11/26/2008EP1594492B1 Novel inhibitors of formation of advanced glycation endproducts (ages)
11/26/2008EP1523239B1 Use of a composition and a cleaning tablet containing said composition for disinfecting purposes
11/26/2008EP1506162B1 Synthesis of benzonitriles and benzimidates
11/26/2008EP1480595B1 Use of esters of long-chain fatty acids for treatment of autoimmune diseases
11/26/2008EP1438296B1 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/26/2008EP1421070B1 New piperidinyl derivates as modulators of chemokine receptor activity
11/26/2008EP1414455B1 Isoquinoline inhibitors of p38
11/26/2008EP1381382B1 Methods and compositions for the treatment of diseases of the eye
11/26/2008EP1337517B1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
11/26/2008EP1173481B1 Inactivated cytokines for immunisation
11/26/2008EP0865293B1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling
11/26/2008CN101313068A Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
1 ... 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 ... 1798